{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:34:44Z","timestamp":1762979684544,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.psyneuen.2009.04.017","type":"journal-article","created":{"date-parts":[[2009,6,6]],"date-time":"2009-06-06T04:09:32Z","timestamp":1244261372000},"page":"1586-1589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3\u03b1,5\u03b1-tetrahydrodeoxycorticosterone concentrations"],"prefix":"10.1016","volume":"34","author":[{"given":"Peter","family":"Zwanzger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Eser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"di Michele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Baghai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2009.04.017_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.psychres.2004.11.009","article-title":"Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder","volume":"135","author":"Brambilla","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2009.04.017_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.npp.1300572","article-title":"Panic induction with cholecystokinin-tetrapeptide (CCK-4) increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers","volume":"30","author":"Eser","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2009.04.017_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-007-0738-7","article-title":"Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study","volume":"192","author":"Eser","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2009.04.017_bib4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archpsyc.58.6.556","article-title":"Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy","volume":"58","author":"Goddard","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2009.04.017_bib5","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archpsyc.65.10.1166","article-title":"Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography","volume":"65","author":"Hasler","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2009.04.017_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G","article-title":"Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers","volume":"8","author":"Koszycki","year":"1998","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psyneuen.2009.04.017_bib7","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1073\/pnas.88.10.4553","article-title":"Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain","volume":"88","author":"Purdy","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.psyneuen.2009.04.017_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0074-7742(02)49014-9","article-title":"Neurosteroids and infantile spasms: the deoxycorticosterone hypothesis","volume":"49","author":"Rogawski","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.psyneuen.2009.04.017_bib9","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","article-title":"Effects of antidepressant treatment on neuroactive steroids in major depression","volume":"155","author":"Romeo","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2009.04.017_bib10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0166-2236(99)01399-5","article-title":"Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives","volume":"22","author":"Rupprecht","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.psyneuen.2009.04.017_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/eje.0.1450669","article-title":"Neurosteroid metabolism in the human brain","volume":"145","author":"Stoffel-Wagner","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.psyneuen.2009.04.017_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.159.1.145","article-title":"GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment","volume":"159","author":"Strohle","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2009.04.017_bib13","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.93.22.12599","article-title":"Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography","volume":"93","author":"Uzunov","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.psyneuen.2009.04.017_bib14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4088\/JCP.v62n0813d","article-title":"Tiagabine improves panic and agoraphobia in panic disorder patients","volume":"62","author":"Zwanzger","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2009.04.017_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/da.10099","article-title":"Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers","volume":"18","author":"Zwanzger","year":"2003","journal-title":"Depress. Anxiety"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453009001474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453009001474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:34:18Z","timestamp":1759682058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453009001474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0306453009001474"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2009.04.017","relation":{},"ISSN":["0306-4530"],"issn-type":[{"type":"print","value":"0306-4530"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3\u03b1,5\u03b1-tetrahydrodeoxycorticosterone concentrations","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2009.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}